Feb 13 (Reuters) - GULF PHARMACEUTICAL INDUSTRIES (JULPHAR):
* FY NET LOSS 564 MILLION DIRHAMS VERSUS LOSS OF 617.8 MILLION DIRHAMS YEAR AGO
* FY REVENUES 299 MILLION DIRHAMS VERSUS 772.3 MILLION DIRHAMS YEAR AGO
* FY NET SALES DECREASED DUE TO TEMPORARY SUSPENSION OF BUSINESS OPERATIONS IN SAUDI ARABIA, KUWAIT AND OMAN Source:(bit.ly/2HiGWcz) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.